Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens

Journal of Dental Research

Volumn 85, Issue 3, 2006, Pages 235-239

  Bodet, C ^a   Chandad, F ^a   Grenier, D ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Anti inflammatory; Cranberry; Cytokine; Macrophage; Periodoritopathogen

Indexed keywords

AUTACOID; CYTOKINE; INTERLEUKIN DERIVATIVE; LIPOPOLYSACCHARIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT MEDICINAL PRODUCT; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANAEROBIC BACTERIUM; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CRANBERRY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MACROPHAGE; METABOLISM; MOLECULAR WEIGHT;

ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACTERIA, ANAEROBIC; CELLS, CULTURED; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MOLECULAR WEIGHT; PLANT PREPARATIONS; RANTES; TUMOR NECROSIS FACTOR-ALPHA; VACCINIUM MACROCARPON;

EID: 33645130043     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910608500306     Document Type: Article

References (28)

1. Assuma R, Oates T, Cochran D, Amar S, Graves DT (1998). IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 160:403-409.
2. Darveau RP, Hancock RE (1983). Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 155:831-838.
3. Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ (2004). A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr 134:1529-1535.
4. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2001). Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 36:194-203.
5. Grenier D (1996). Degradation of host protease inhibitors and activation of plasminogen by proteolytic enzymes from Porphyromonas gingivalis and Treponema denticola. Microbiology 142(Pt 4):955-961.
6. Haffajec AD, Socransky SS (1994). Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 5:78-111.
7. Henderson B, Poole S, Wilson M (1996). Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 60:316-341.
8. Hou LT, Liu CM, Rossomando EF (1995). Crevicular interleukin-1 beta in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 22:162-167.
9. Kim HP, Son KH, Chang HW, Kang SS (2004). Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 96:229-245.
10. Kornman KS (1999). Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis 28:520-526.
11. Kornman KS, Page RC, Tonetti MS (1997). The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 14:33-53.
12. Lima V, Vidal FD, Rocha FA, Brito GA, Ribeiro RA (2004). Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats. J Periodontol 75:162-168.
13. Luster AD (1998). Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445.
14. Okada H, Murakami S (1998). Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 9:248-266.
15. Paquette DW, Williams RC (2000). Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000 24:239-252.
16. Raz R, Chazan B, Dan M (2004). Cranberry juice and urinary tract infection. Clin Infect Dis 38:1413-1419.
17. Rovera G, Santoli D, Damsky C (1979). Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA 76:2779-2783.
18. Schultz CP, Wolf V, Lange R, Mertens E, Wecke J, Naumann D, et al. (1998). Evidence for a new type of outer membrane lipid in oral spirochete Treponema denticola. Functioning permeation barrier without lipopolysaccharides. J Biol Chem 273:15661-15666.
19. Seeram NP, Adams LS, Hardy ML, Heber D (2004). Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem 52:2512-2517.
20. Steinberg D, Feldman M, Ofek I, Weiss EI (2004). Effect of a high-molecular-weight component of cranberry on constituents of dental biofilm. J Antimicrob Chemother 54:86-89.
21. Steinberg D, Feldman M, Ofek I, Weiss EI (2005). Cranberry high molecular weight constituents promote Streptococcus sobrinus desorption from artificial biofilm. Int J Antimicrob Agents 25:247-251.
22. Weiss EI, Lev-Dor R, Kashamn Y, Goldhar J, Sharon N, Ofek I (1998). Inhibiting interspecies coaggregation of plaque bacteria with a cranberry juice constituent. J Am Dent Assoc 129:1719-1723.
23. [Published erratum appears in J Am Dent Assoc 130(1):36
24. and J Am Dent Assoc 130(3):332, 1999.]
25. Weiss EI, Kozlovsky A, Steinberg D, Lev-Dor R, Bar Ness Greenstein R, Feldman M, et al. (2004). A high molecular mass cranberry constituent reduces mutans streptococci level in saliva and inhibits in vitro adhesion to hydroxyapatite. FEMS Microbiol Lett 232:89-92.
26. Yamanaka A, Kimizuka R, Kato T, Okuda K (2004). Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Oral Microbiol Immunol 19:150-154.
27. Yang F, de Villiers WJ, McClain CJ, Varilek GW (1998). Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 128:2334-2340.
28. Zappa U, Reinking-Zappa M, Graf H, Espeland M (1991). Cell populations and episodic periodontal attachment loss in humans. J Clin Periodontol 18:508-515.